Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Oct 14 (Reuters) — Swiss contract drug manufacturer Lonza set new mid-term targets and confirmed its 2026 outlook on Wednesday ahead of its capital markets day, while saying third-quarter performance was in line with expectations across its business areas. Lonza is seeking to become a pure-play drug manufacturer once i
Lonza set new mid-term targets and confirmed its 2026 outlook ahead of its capital markets day. It said third-quarter performance was in line with expectations across its business areas.